Literature DB >> 9699900

Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites.

A P Boright1, P W Connelly, J H Brunt, S W Scherer, L C Tsui, R A Hegele.   

Abstract

In a sample taken from the genetically isolated Alberta Hutterites, we previously found that PON1 variation was associated with variation in plasma lipoprotein traits, including LDL and HDL cholesterol. With the recent cloning of the PON1-related gene PON2, we undertook studies of the association between genetic variation in PON2 and variation in plasma quantitative traits variation in a sample of 745 Alberta Hutterites. We found novel genetic associations between PON2 variation and variation in fasting plasma concentrations of total cholesterol and apolipoprotein AI. We confirmed our previously observed significant associations in this study sample between PON1 genetic variation and variation in plasma apo B-related traits, such as LDL, non-HDL and HDL cholesterol and apo B itself. Furthermore, there was almost complete linkage disequilibrium between PON2 alleles G148 and C311. We found no association between PON2 variation and plasma glucose or insulin. Taken together, our results suggest that common genetic variation on chromosome 7q21.3-22.1 in both PON1 and PON2 that affects the amino acid sequence of the respective gene products is associated with significant variation in intermediate traits in plasma lipoprotein metabolism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699900     DOI: 10.1016/s0021-9150(98)00071-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

1.  Evidence of linkage of familial hypoalphalipoproteinemia to a novel locus on chromosome 11q23.

Authors:  E N Kort; D G Ballinger; W Ding; S C Hunt; B R Bowen; V Abkevich; K Bulka; B Campbell; C Capener; A Gutin; K Harshman; M McDermott; T Thorne; H Wang; B Wardell; J Wong; P N Hopkins; M Skolnick; M Samuels
Journal:  Am J Hum Genet       Date:  2000-04-17       Impact factor: 11.025

Review 2.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

3.  Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus.

Authors:  Sudeshna Dasgupta; F Yesim Demirci; Amy S Dressen; Amy H Kao; Elisa Y Rhew; Rosalind Ramsey-Goldman; Susan Manzi; Candace M Kammerer; M Ilyas Kamboh
Journal:  BMC Med Genet       Date:  2011-01-11       Impact factor: 2.103

Review 4.  Paraoxonase gene polymorphisms, oxidative stress, and diseases.

Authors:  Hong-Liang Li; De-Pei Liu; Chih-Chuan Liang
Journal:  J Mol Med (Berl)       Date:  2003-10-09       Impact factor: 4.599

5.  Serum paraoxonase 1 activity status in patients with liver disorders.

Authors:  Vivekananda Kedage; Manjunatha S Muttigi; Mahesh S Shetty; Renuka Suvarna; Soumya S Rao; Chitralekha Joshi; Mungli Prakash
Journal:  Saudi J Gastroenterol       Date:  2010 Apr-Jun       Impact factor: 2.485

6.  Protectors or Traitors: The Roles of PON2 and PON3 in Atherosclerosis and Cancer.

Authors:  Ines Witte; Ulrich Foerstermann; Asokan Devarajan; Srinivasa T Reddy; Sven Horke
Journal:  J Lipids       Date:  2012-05-13

Review 7.  Human paraoxonase 2.

Authors:  Sureerut Porntadavity; Thinnakorn Permpongpaiboon; Wanida Sukketsiri
Journal:  EXCLI J       Date:  2010-11-26       Impact factor: 4.068

8.  A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia.

Authors:  Robert A Hegele; Matthew R Ban; Neil Hsueh; Brooke A Kennedy; Henian Cao; Guang Yong Zou; Sonia Anand; Salim Yusuf; Murray W Huff; Jian Wang
Journal:  Hum Mol Genet       Date:  2009-08-05       Impact factor: 6.150

9.  Increased influence of genetic variation on PON1 activity in neonates.

Authors:  Jia Chen; Madhu Kumar; Wendy Chan; Gertrud Berkowitz; James G Wetmur
Journal:  Environ Health Perspect       Date:  2003-08       Impact factor: 9.031

10.  Paraoxonase gene polymorphisms and haplotype analysis in a stroke population.

Authors:  Alireza Pasdar; Helen Ross-Adams; Alastair Cumming; John Cheung; Lawrence Whalley; David St Clair; Mary-Joan MacLeod
Journal:  BMC Med Genet       Date:  2006-03-21       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.